Treatment Patterns in US Patients Receiving First-Line and Second-Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma in the Real World

INTRODUCTION: Metastatic pancreatic ductal adenocarcinoma (mPDAC) is a common cancer with poor survival outcomes. Although treatment options are limited, real-world treatment patterns and outcomes are not well understood, particularly beyond first-line treatment. This study described real-world trea...

Descripción completa

Detalles Bibliográficos
Autores principales: King, Gentry, Ittershagen, Stacie, He, Luyang, Shen, Ying, Li, Frank, Villacorta, Reginald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618512/
https://www.ncbi.nlm.nih.gov/pubmed/36197644
http://dx.doi.org/10.1007/s12325-022-02317-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618512/
https://www.ncbi.nlm.nih.gov/pubmed/36197644
http://dx.doi.org/10.1007/s12325-022-02317-9

Ejemplares similares